← Back to Search

Immunomodulator

Imiquimod cream for Actinic Keratosis

Phase 4
Waitlist Available
Research Sponsored by Medicis Global Service Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 14 of each treatment period
Awards & highlights

Study Summary

The purpose of this study is to determine the potential effect of topically applied 3.75% imiquimod cream on atrial ectopy in actinic keratosis (AK) patients. The primary endpoint is the change in the 24-hour supraventricular premature beat count. The secondary endpoint is the change in 24-hour supraventricular premature couplet and run counts and atrial fibrillation (% time); change in 24-hour mean heart rate; change in 24-hour ventricular premature beat count, ventricular premature couplet and run counts.

Eligible Conditions
  • Actinic Keratosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 14 of each treatment period
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 14 of each treatment period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in 24-hour supraventricular beat count
Secondary outcome measures
Change in 24-hour mean heart rate
Change in 24-hour supraventricular premature couplet and run counts and atrial fibrillation (% time)
Premature Cardiac Complex

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Imiquimod creamActive Control1 Intervention
Group II: Placebo creamPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Medicis Global Service CorporationLead Sponsor
11 Previous Clinical Trials
2,655 Total Patients Enrolled
Robert W Babilon, MS, MBAStudy DirectorGraceway Pharmaceuticals, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
2011. "Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01413763.
All > Actinic Keratosis
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top